Skip to main content

Peer Review reports

From: Designing the selenium and bladder cancer trial (SELEBLAT), a phase lll randomized chemoprevention study with selenium on recurrence of bladder cancer in Belgium

Original Submission
12 Feb 2012 Submitted Original manuscript
23 Feb 2012 Author responded Author comments - Maria Goossens
Resubmission - Version 2
23 Feb 2012 Submitted Manuscript version 2
Publishing
21 Mar 2012 Editorially accepted
21 Mar 2012 Article published 10.1186/1471-2490-12-8

You can find further information about peer review here.

Back to article page

BMC Urology

ISSN: 1471-2490

Contact us